Reference : BM-613, a new thromboxane A2 antagonist, is characterized by a preferential activity ...
Scientific congresses and symposiums : Poster
Human health sciences : Pharmacy, pharmacology & toxicology
http://hdl.handle.net/2268/68726
BM-613, a new thromboxane A2 antagonist, is characterized by a preferential activity on platelet thromboxane A2 receptors
English
Hanson, Julien mailto [Université de Liège - ULg > Département de pharmacie > Chimie pharmaceutique >]
Rolin, S. [ > > ]
De Leval, X. [ > > ]
Neven, P. [ > > ]
Masereel, B. [ > > ]
Pirotte, Bernard mailto [Université de Liège - ULg > Département de pharmacie > Chimie pharmaceutique >]
Dogne, J. M. [ > > ]
Dec-2003
Yes
International
45th ASH Annual Meeting
6-9 décembre 2003
san Diego
USA
http://hdl.handle.net/2268/68726

There is no file associated with this reference.

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.